Term
single most important aspect of the exam |
|
Definition
|
|
Term
"Don't cal(l)" acronym for Hx of chief complaint |
|
Definition
D - duration O - onset N - nature of pain/injury T - treatment done by pt C - course A - aggravating factors L - location |
|
|
Term
important question for PSHX |
|
Definition
|
|
Term
associated with a wide pulse pressure (>60 mm Hg) |
|
Definition
|
|
Term
causes for delay in subpapillary venous plexus filling time (SVPFT) |
|
Definition
vasospasm or structural change |
|
|
Term
systemic diseases causing pitting edema |
|
Definition
|
|
Term
systemic diseases causing non-pitting edema |
|
Definition
liver and kidney problems - lack of protein in exudate |
|
|
Term
non-palpable lesion, less than .5 cm |
|
Definition
|
|
Term
non-palpable lesion, greater than .5 cm |
|
Definition
|
|
Term
palpable, solid lesion, less than .5 cm |
|
Definition
|
|
Term
palpable, solid lesion, .5 to 1 cm |
|
Definition
|
|
Term
palpable, solid lesion, greater than 1 cm |
|
Definition
|
|
Term
palpable, solid lesion, greater than .5 cm with a flat elevated surface formed by coalescence of papules |
|
Definition
|
|
Term
clear, fluid filled lesion, less than .5 cm |
|
Definition
|
|
Term
clear, fluid filled lesion, greater than .5 cm |
|
Definition
|
|
Term
cloudy, pus filled lesion, less than .5 cm |
|
Definition
|
|
Term
cloudy, pus filled lesion, greater than .5 cm |
|
Definition
|
|
Term
erosion, crust, scale, fissure, ulcer, lichenification, atrophy, excoriation, scar, keloid |
|
Definition
|
|
Term
two courses for sensory impulses after entry into the dorsal spinal cord |
|
Definition
posterior column or lateral spinothalamic tract |
|
|
Term
small fiber tract C-fibers and A-delta fibers sharp and dull pain (nociceptive), temperature and crude touch burning and cramping |
|
Definition
|
|
Term
large fiber tract A-alpha fibers position, vibration and fine touch pins and needles and electric shock |
|
Definition
|
|
Term
abnormal SW monofilament test |
|
Definition
inability to detect pressure in more than 3 areas |
|
|
Term
|
Definition
128 cycle/sec tuning fork over the IPJ of the hallux loss of vibration in <10 seconds is abnormal |
|
|
Term
objective measures of sensory nerve function |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
a technique involving isometric contraction of other muscles that may increase reflex activity |
|
|
Term
Deep reflexes are dependent upon.... |
|
Definition
an intact sensory nerve a functional synapse in the spinal cord an intact motor nerve fiber a neuromuscular junction a competent muscle |
|
|
Term
|
Definition
indicates upper motor neuron disease |
|
|
Term
|
Definition
lower motor neuron disease peripheral neuropathy |
|
|
Term
|
Definition
may be impaired in lesions of the sensory cortex or posterior column |
|
|
Term
may reveal early loss in the feet |
|
Definition
changes in the extensor digitorum brevis |
|
|
Term
occurs in more severe neuropathies |
|
Definition
ankle dorsiflexion weakness |
|
|
Term
evident in only the most severe cases of neuropathy |
|
Definition
ankle plantarflexion weakness |
|
|
Term
patient is able to stand on tiptoes but not on heels |
|
Definition
suggest peripheral neuropathy |
|
|
Term
patient is able to stand on heels but not on tiptoes |
|
Definition
|
|
Term
geared towards an orthopedic physical examination |
|
Definition
|
|
Term
important question for prenatal Hx |
|
Definition
was the mother aware of fetal movements beginning in the 4th month of pregnancy |
|
|
Term
|
Definition
|
|
Term
hand preference before the age of 2 |
|
Definition
could signify a neuromuscular problem |
|
|
Term
|
Definition
lift head - 3 months control head position while sitting - 6 months crawls - 6 months pulls self to stand - 9 months walks - 14 months ascends stairs with 2 hand support - 18 months run forward - 2 years pedal tricycle - 3 years balance or hop on one foot - 4 years heel-toe walk - 5 years skip one foot at a time - 6 years |
|
|
Term
|
Definition
used for return visits for established patients |
|
|
Term
order for a specific med for a specific pt at a particular time |
|
Definition
|
|
Term
Composition of the prescription order (SISSY) |
|
Definition
S - superscription I - inscription S - subscription S - signa Y - your signature |
|
|
Term
|
Definition
directions to the patient |
|
|
Term
may be renewed not more than 5 times within six months |
|
Definition
|
|
Term
|
Definition
|
|
Term
high potential for abuse with no currently accepted medical use in the U.S. not available with a prescription may be obtained for research |
|
Definition
|
|
Term
high abuse potential with severe psychological or physical dependence opioids, amphetamines, sedatives, codeine, sulfate, codeine, phosphate, oxycodone Hcl, Ritalin, Amytal, Nembutal |
|
Definition
|
|
Term
Less potential for abuse low or moderate physical dependence or high pychological dependence Tylenol w/codeine, cough medicines containing hydrocodone, anabolic steroids |
|
Definition
|
|
Term
limited physical or psychological dependence valium |
|
Definition
|
|
Term
potential for abuse is low codeine-containing cough mixtures some may be dispensed without a prescription |
|
Definition
|
|
Term
drugs for which the prescriber must provide a written prescription to the pharmacist |
|
Definition
|
|
Term
most common drugs implicated in adverse events |
|
Definition
amoxicillin aspirin bactrim vicodin ibuprofen acetaminophen cephalexin penicillin |
|
|
Term
most commonly mishandled drugs leading to errors by physicians |
|
Definition
morphine vancomycin cefazolin acetaminophen |
|
|
Term
|
Definition
CBC (lavender topped) metabolic profile (red topped) |
|
|
Term
Comprehensive metabolic panel |
|
Definition
basic metabolic profile, plus liver profile |
|
|
Term
|
Definition
increased - dehydration, renal failure, cardiac failure decreased- vomiting, diarrhea |
|
|
Term
|
Definition
3.5-5.0 meq/L decreased - increased renal excretion low values can trigger arrhythmias |
|
|
Term
|
Definition
9-24 mg/dL increased - renal failure, dehydration |
|
|
Term
|
Definition
0.7-1.4 mg/dL increased - renal failure |
|
|
Term
|
Definition
|
|
Term
|
Definition
8.5-10.5 mg/dL increased - primary hyperparathyroidism, renal osteodystrophy, bony metastases |
|
|
Term
|
Definition
increased - under 20 years of age, increased bone production (Paget's disease, healing fractures, osteoblastic bone tumors or mets, hyperparathyroidism) |
|
|
Term
|
Definition
produced only by the liver increased - hepatocellular damage |
|
|
Term
|
Definition
produced in liver, cardiac and smooth muscle, kidney, brain, pancreas, lung, WBC, RBC increased - hepatocellular damage |
|
|
Term
ALT and AST levels twice the baseline |
|
Definition
ALT and AST levels that cause concern |
|
|
Term
|
Definition
increased - hemolytic anemias, Gilbert's disease |
|
|
Term
|
Definition
3.5-5.0 gm/dL sometimes used along with total lymphocyte count as predictors of healing in diabetics chances of healing increase if levels are greater than 3.0 |
|
|
Term
Glucose + in chemical urinalysis |
|
Definition
when serum level exceeds 1700 mg/dL |
|
|
Term
|
Definition
blood- negative nitrite - negative (suggests bacterial action) leukocyte alkaline esterase - detects PMNs |
|
|
Term
|
Definition
RBCs : 1-2/hpf WBCs : > 10/mm^3 suggests UTI |
|
|
Term
|
Definition
|
|
Term
|
Definition
cholestatic disease augmentin, oral hypoglycemics, EES |
|
|
Term
|
Definition
divide male age by 2 divide female age _ 10 years by 2 increased - infection, inflamation >70 in presence of infection is suggestive of osteomyelitis highest levels seen in PMR |
|
|
Term
|
Definition
<0.8 mg/dL increased - infection, inflammation, cardiac marker >3.2 with an ulcer >3.0 mm in depth suggests osteomyelitis unlike ESR (sed rate) it increases rapidly |
|
|
Term
|
Definition
>80 IU strongly suggests active RA |
|
|
Term
|
Definition
5% of healthy persons have a positive test result - positive predictive screening value of 1% negative test excludes Dx of SLE can be positive in rheumatic diseases |
|
|
Term
titer at which ANA is believed to show clinical significance |
|
Definition
|
|
Term
|
Definition
goal is <6/4 mg increased - gout, renal failure, leukemias, lymphomas, metastatic CA, thiazides, salicylates |
|
|
Term
CPK (creatine phosphokinase |
|
Definition
increased - skeletal muscle, exercise, IM injections |
|
|
Term
|
Definition
increased in skeletal muscle disease |
|
|
Term
|
Definition
13 seconds, INR 1.0 used to monito coumadin therapy (usually an INR of 1.5-2.0) |
|
|
Term
|
Definition
27-35 seconds used to monitor heparin therapy (usually at 60-90 seconds) |
|
|
Term
most requested tests for podiatrists |
|
Definition
|
|
Term
|
Definition
measures long-term control (90 days) of blood glucose <7.0 |
|
|
Term
|
Definition
blood glucose = (33.3 x HbA1c) - 86 |
|
|
Term
slide test with KOH (10-20%) |
|
Definition
identifies dermatophytes on skin or nail scraping |
|
|
Term
Complex Regional Pain Syndrome (CRPS) |
|
Definition
poorly understood, chronic inflammatory neuropathic pain disorder |
|
|
Term
|
Definition
usually occurs after trauma |
|
|
Term
|
Definition
may develop after trauma without definable nerve damage most common form "reflex sympathetic dystrophy" |
|
|
Term
|
Definition
"Causalgia" same presentation but there is identifiable nerve injury (nerve injury is not complete) |
|
|
Term
|
Definition
new category for patients with <3 symptoms or <2 sign categories whose SSx best explained by CRPS |
|
|
Term
|
Definition
pain out of proportion allodynia and hyperesthesia pain doesn't follow dermatome and can spread beyond area of injury pain described as severe and burning, throbbing or aching |
|
|
Term
|
Definition
skin warm, red and dry, then may become blue and cold may have hyperhydrosis edema severe pain with allodynia and hyperalgesia |
|
|
Term
CRPS stage II - dystrophic |
|
Definition
pain becomes more severe and diffuse edema becomes more hardened and limb can appear brawny hair and nail changes (brittle) X-ray changes muscle wasting begins |
|
|
Term
CRPS stage III - atrophic |
|
Definition
pain may start decreasing but motor and trophic changes increase tissue wasting occurs and can become permanent |
|
|
Term
diagnostic sympathetic ganglion block |
|
Definition
useful for purely sympathetically mediated disease |
|
|
Term
|
Definition
|
|
Term
1st line, short term treatment for CRPS |
|
Definition
corticosteroids (not recommended for use over 1 month) |
|
|
Term
|
Definition
|
|